LifeSensors ubiquitin ligase and proteasome inhibitors

Tuesday, 12 November, 2013 | Supplied by: United Bioresearch Products Pty Ltd


LifeSensors has added several small molecule ubiquitin ligase and proteasome inhibitors to its range.

Carfilzomib is the active ingredient in the new clinical proteasome inhibitor Kyprolis.

Epoxomicin/BU-4061T is one of the most potent and selective proteasome inhibitors.

Oprozomib/ONX0912 is a clinical-stage proteasome inhibitor that selectively inhibits the chymotrypsin-like activity of the 20S proteasome.

MLN2238 is a potent inhibitor of the chymotrypsin-like activity of the 20S proteasome.

RITA/NSC652287 blocks p53-hdm2 interaction and p53 ubiquitination.

SKPin C1 inhibits the cullin-RING ubiquitin E3 ligase SCF-Skp2.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Dojindo Cell Counting Kit-8 (CCK-8)

The Cell Counting Kit-8 (CCK-8) from Dojindo is a pre-mixed, nonradioactive one-bottle solution...

Cayman Chemical Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit

Cayman Chemical's Total Iron-Binding Capacity (TIBC) and Serum Iron Assay Kit provides a...

Sphere Fluidics Cyto-Mine single-cell analysis system for cell line development

Sphere Fluidics' Cyto-Mine is a single-cell analysis platform that enables individual cells...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd